These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir. Dunn DL; Mayoral JL; Gillingham KJ; Loeffler CM; Brayman KL; Kramer MA; Erice A; Balfour HH; Fletcher CV; Bolman RM Transplantation; 1991 Jan; 51(1):98-106. PubMed ID: 1846255 [TBL] [Abstract][Full Text] [Related]
13. Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study. Sagedal S; Nordal KP; Hartmann A; Midtvedt K; Foss A; Asberg A; Degré M; Fauchald P; Rollag H Nephrol Dial Transplant; 2003 Sep; 18(9):1899-908. PubMed ID: 12937241 [TBL] [Abstract][Full Text] [Related]
14. Pharmacoepidemiology of cytomegalovirus prophylaxis in a large retrospective cohort of kidney transplant recipients with Medicare Part D coverage. Santos CA; Brennan DC; Saeed MJ; Fraser VJ; Olsen MA Clin Transplant; 2016 Apr; 30(4):435-44. PubMed ID: 26841129 [TBL] [Abstract][Full Text] [Related]
15. [A case report of CMV hepatitis and nephropathy after living related renal transplantation]. Tanaka S; Fujioka M; Sasaki S Nihon Geka Gakkai Zasshi; 1993 Dec; 94(12):1305-8. PubMed ID: 8272070 [TBL] [Abstract][Full Text] [Related]
16. A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Flechner SM; Avery RK; Fisher R; Mastroianni BA; Papajcik DA; O'Malley KJ; Goormastic M; Goldfarb DA; Modlin CS; Novick AC Transplantation; 1998 Dec; 66(12):1682-8. PubMed ID: 9884259 [TBL] [Abstract][Full Text] [Related]
17. Leflunomide as a rescue treatment in ganciclovir-resistant cytomegalovirus infection in a seronegative renal transplant recipient--a case report. Ciszek M; Mucha K; Foroncewicz B; Chmura A; Pączek L Ann Transplant; 2014 Jan; 19():60-3. PubMed ID: 24481271 [TBL] [Abstract][Full Text] [Related]
18. Severe cytomegalovirus ureteritis in a renal allograft recipient with negative CMV monitoring. Vaessen C; Kamar N; Mehrenberger M; Mazerolles C; Mengelle C; Rischmann P; Rostaing L; Malavaud B Nephrol Dial Transplant; 2005 Jan; 20(1):227-30. PubMed ID: 15632357 [No Abstract] [Full Text] [Related]
19. The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival. Smedbråten YV; Sagedal S; Leivestad T; Mjøen G; Osnes K; Rollag H; Reisaeter AV; Foss A; Os I; Hartmann A Clin Transplant; 2014 Jan; 28(1):120-6. PubMed ID: 24351078 [TBL] [Abstract][Full Text] [Related]
20. Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report. Iwami D; Ogawa Y; Fujita H; Morita K; Sasaki H; Oishi Y; Higuchi H; Hatanaka K; Shinohara N Nephrology (Carlton); 2016 Jul; 21 Suppl 1():63-6. PubMed ID: 26970406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]